257 related articles for article (PubMed ID: 29517680)
21. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature.
Herrera JD; Davidson JA; Mestman JH
Endocr Pract; 2009 Mar; 15(2):149-52. PubMed ID: 19289327
[TBL] [Abstract][Full Text] [Related]
22. Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization.
Shakir MKM; Snitchler AN; Vietor NO; Mai VQ; Hoang TD
AACE Clin Case Rep; 2021; 7(1):26-28. PubMed ID: 33851015
[TBL] [Abstract][Full Text] [Related]
23. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
Waggoner W; Boots LR; Azziz R
Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
[TBL] [Abstract][Full Text] [Related]
24. Hyperandrogenism in a postmenopausal woman: a rare case of ectopic adrenal cortical gland.
Guarino A; Di Benedetto L; Giovanale V; Rampioni Vinciguerra GL; Stoppacciaro A; Bellati F; Caserta D
Gynecol Endocrinol; 2017 Mar; 33(3):185-187. PubMed ID: 28102088
[TBL] [Abstract][Full Text] [Related]
25. Occult symptomatic bilateral pure Leydig cell tumors in a postmenopausal woman: a case report.
Hussain SA; Dubil EA; De Luca-Johnson JN; Johnston M
Gynecol Endocrinol; 2021 Jul; 37(7):672-675. PubMed ID: 34137345
[TBL] [Abstract][Full Text] [Related]
26. Postmenopausal Hyperandrogenism Associated With Synchronous Ovarian Brenner Tumor, Bilateral Leydig Cell Tumor, and Adrenal Mass.
Salim M; Dasaraju S; Erickson B; Khalifa M; Burmeister LA
Cureus; 2024 Mar; 16(3):e55334. PubMed ID: 38559537
[TBL] [Abstract][Full Text] [Related]
27. [A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary].
Marcelino M; Nobre E; Conceição J; Lopes L; Vilar H; França Martins M; Carvalho A; André S; Horta A; De Castro JJ
Acta Med Port; 2010; 23(1):113-8. PubMed ID: 20353714
[TBL] [Abstract][Full Text] [Related]
28. Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.
Sanz OA; Martinez PR; Guarch RT; Goñi MJ; Alcazar JL
Maturitas; 2007 Jun; 57(2):214-6. PubMed ID: 17289310
[TBL] [Abstract][Full Text] [Related]
29. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
[TBL] [Abstract][Full Text] [Related]
30. An unusual circulating steroid profile in a virilized postmenopausal woman.
Benavent Correro P; Sáenz Valls M; García Cano A; Jiménez Mendiguchia L; Moreno Moreno E; Luque-Ramírez M
Diagnosis (Berl); 2018 Jun; 5(2):83-87. PubMed ID: 29752879
[TBL] [Abstract][Full Text] [Related]
31. Leydig cell hyperplasia as a cause of virilization in a postmenopausal woman: A case report.
Vatopoulou A; Gkrozou F; Birbas E; Kanavos T; Skentou C; Miliaras D
Case Rep Womens Health; 2023 Sep; 39():e00537. PubMed ID: 37692362
[TBL] [Abstract][Full Text] [Related]
32. Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration - case report and review of the literature.
Klotz RK; Müller-Holzner E; Fessler S; Reimer DU; Zervomanolakis I; Seeber B; Mattle V; Wildt L
Exp Clin Endocrinol Diabetes; 2010 May; 118(5):291-7. PubMed ID: 20198556
[TBL] [Abstract][Full Text] [Related]
33. [Hyperandrogenism after menopause: Ovarian or adrenal origin?].
Sarfati J; Moraillon-Bougerolle M; Christin-Maitre S
Gynecol Obstet Fertil Senol; 2022 Oct; 50(10):675-681. PubMed ID: 35609786
[TBL] [Abstract][Full Text] [Related]
34. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
35. Postmenopausal hyperandrogenism caused by a benign cystic teratoma: a case report.
Wu DH; McMurtrie DG; Hirsch SD; Johnston CM
J Reprod Med; 2008 Feb; 53(2):141-4. PubMed ID: 18357809
[TBL] [Abstract][Full Text] [Related]
36. Marked hyperandrogenicity in a 60-year-old woman.
Aljenaee K; Ali S; Cheah SK; MacEneaney O; Mulligan N; Hickey N; Tun TK; Sreenan S; McDermott JH
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28924479
[TBL] [Abstract][Full Text] [Related]
37. SEVERE HYPERANDROGENISM IN A PREMENOPAUSAL WOMAN WITH AN IMAGING-NEGATIVE LEYDIG CELL TUMOR.
Lubchansky SB; McManus R
AACE Clin Case Rep; 2020; 6(6):e290-e294. PubMed ID: 33244487
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of selective venous catheterization in localizing a small androgen-producing tumor in ovary.
Nishiyama S; Hirota Y; Udagawa Y; Kato R; Hayakawa N; Tukada K
Med Sci Monit; 2008 Feb; 14(2):CS9-12. PubMed ID: 18227769
[TBL] [Abstract][Full Text] [Related]
39. The Masquerading, Masculinizing Tumor: A Case Report and Review of the Literature.
LeVee A; Suppogu N; Walsh C; Sacks W; Simon J; Shufelt C
J Womens Health (Larchmt); 2021 Jul; 30(7):1047-1051. PubMed ID: 32991246
[TBL] [Abstract][Full Text] [Related]
40. The case of the elusive androgen.
Cobin RH
Endocr Pract; 2002; 8(6):433-8. PubMed ID: 15260009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
